Translational Research Institute
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. The TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
Mater Research is one of four founding institutes which partnered to establish the TRI in 2012, and form this unique collaboration with more than 650 researchers.
Led by Professor Carolyn Mountford, the TRI brings together the best and brightest minds from Mater Research, The University of Queensland Diamantina Institute, Queensland University of Technology Institute of Health and Biomedical Innovation and Princess Alexandra Hospital Centres for Health Research.
The collective expertise of these partners will be brought to bear on common and serious disease including cancers, diabetes, inflammatory diseases, HIV, malaria, bone and joint diseases and obesity, with a view to enhanced prevention and treatment and improved public health worldwide.
Incorporation of a biopharmaceutical manufacturing was a key part of the vision and was planned to facilitate in a single location the discovery, production, clinical testing and manufacture of new treatments and vaccines.
To contact Mater Research at TRI please call 3443 7200.
For more information visit www.tri.edu.au